You just read:

ENSURE-AF Data Support the Efficacy and Safety Profile of Daiichi Sankyo's Once-Daily LIXIANA®▼ (edoxaban) in Patients with Atrial Fibrillation Undergoing Cardioversion

News provided by

Daiichi Sankyo Company, Limited

30 Aug, 2016, 08:00 BST